Trastuzumab deruxtecan (T-DXd) plus pertuzumab (P) vs taxane plus trastuzumab plus pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic breast cancer (a/mBC): Interim results from DESTINY-Breast09.

상세 보기

Citations

WEB OF SCIENCE

51

제목: Trastuzumab deruxtecan (T-DXd) plus pertuzumab (P) vs taxane plus trastuzumab plus pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic breast cancer (a/mBC): Interim results from DESTINY-Breast09.

저자: Tolaney, Sara M.; Jiang, Zefei; Zhang, Qingyuan; Barroso-Sousa, Romualdo; Park, Yeon Hee; Rimawi, Mothaffar F.; Saura Manich, Cristina; Schneeweiss, Andreas; Toi, Masakazu; Chae, Yee Soo; Kemal, Yasemin; Chaudhari, Mukesh; Yamashita, Toshinari; Casalnuovo, Monica; Danso, Michael A.; Liu, Jie; Shetty, Jagdish; Herbolsheimer, Pia Maarit; Loibl, Sibylle